CorMedix Inc. to Host Regulatory Update Conference Call

On March 8, 2021 CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, reported that it will host a conference call relating to a regulatory update for DefenCath at 8:30am ET on March 9, 2021 (Press release, CorMedix, MAR 8, 2021, View Source [SID1234576213]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Tuesday, March 9th @ 8:30am ET
Domestic: 877-423-9813
International: 201-689-8573
Conference ID: 13717520
Webcast: Webcast Link